Atossa Genetics Total Assets 2012-2024 | ATOS
Atossa Genetics total assets from 2012 to 2024. Total assets can be defined as the sum of all assets on a company's balance sheet.
| Atossa Genetics Annual Total Assets (Millions of US $) |
|
|---|---|
| 2024 | $76 |
| 2023 | $96 |
| 2022 | $124 |
| 2021 | $141 |
| 2020 | $43 |
| 2019 | $14 |
| 2018 | $12 |
| 2017 | $8 |
| 2016 | $4 |
| 2015 | $6 |
| 2014 | $12 |
| 2013 | $12 |
| 2012 | $7 |
| 2011 | $3 |
| Atossa Genetics Quarterly Total Assets (Millions of US $) |
|
|---|---|
| 2024-12-31 | $76 |
| 2024-09-30 | $79 |
| 2024-06-30 | $86 |
| 2024-03-31 | $91 |
| 2023-12-31 | $96 |
| 2023-09-30 | $102 |
| 2023-06-30 | $108 |
| 2023-03-31 | $116 |
| 2022-12-31 | $124 |
| 2022-09-30 | $127 |
| 2022-06-30 | $134 |
| 2022-03-31 | $137 |
| 2021-12-31 | $141 |
| 2021-09-30 | $143 |
| 2021-06-30 | $146 |
| 2021-03-31 | $141 |
| 2020-12-31 | $43 |
| 2020-09-30 | $11 |
| 2020-06-30 | $10 |
| 2020-03-31 | $12 |
| 2019-12-31 | $14 |
| 2019-09-30 | $17 |
| 2019-06-30 | $19 |
| 2019-03-31 | $21 |
| 2018-12-31 | $12 |
| 2018-09-30 | $14 |
| 2018-06-30 | $17 |
| 2018-03-31 | $6 |
| 2017-12-31 | $8 |
| 2017-09-30 | $4 |
| 2017-06-30 | $5 |
| 2017-03-31 | $2 |
| 2016-12-31 | $4 |
| 2016-09-30 | $6 |
| 2016-06-30 | $3 |
| 2016-03-31 | $5 |
| 2015-12-31 | $6 |
| 2015-09-30 | $12 |
| 2015-06-30 | $17 |
| 2015-03-31 | $14 |
| 2014-12-31 | $12 |
| 2014-09-30 | $17 |
| 2014-06-30 | $20 |
| 2014-03-31 | $22 |
| 2013-12-31 | $12 |
| 2013-09-30 | $13 |
| 2013-06-30 | $10 |
| 2013-03-31 | $9 |
| 2012-12-31 | $7 |
| 2012-09-30 | $6 |
| 2012-06-30 | $0 |
| 2012-03-31 | $0 |
| 2011-12-31 | $0 |
| 2011-09-30 | $0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.107B | $0.000B |
| Atossa Genetics Inc. is a healthcare company focused on the development and marketing of cellular and molecular diagnostic risk assessment products for breast cancer. The Company's diagnostic tests consist of medical devices which can collect fluid samples from the breast milk ducts. It is also conducting research on the treatment of pre-cancerous cells by using its FDA-cleared microcatheters to deliver, directly into the milk ducts, anti-cancer drugs that can be used to treat the pre-cancerous lesions. Atossa Genetics Inc. is headquartered in Seattle, WA. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $190.127B | 83.28 |
| Thermo Fisher Scientific (TMO) | United States | $153.648B | 18.58 |
| Alcon (ALC) | Switzerland | $47.347B | 31.47 |
| Edwards Lifesciences (EW) | United States | $44.043B | 28.82 |
| IDEXX Laboratories (IDXX) | United States | $38.097B | 43.78 |
| DexCom (DXCM) | United States | $31.969B | 49.41 |
| IQVIA Holdings (IQV) | United States | $25.777B | 14.17 |
| Mettler-Toledo (MTD) | United States | $22.100B | 26.28 |
| STERIS (STE) | Ireland | $21.856B | 24.99 |
| Waters (WAT) | United States | $20.170B | 28.47 |
| SONOVA HOLDING (SONVY) | Switzerland | $18.308B | 0.00 |
| Hologic (HOLX) | United States | $11.835B | 12.86 |
| Sysmex ADR (SSMXY) | Japan | $11.715B | 0.00 |
| Penumbra (PEN) | United States | $11.306B | 88.74 |
| Globus Medical (GMED) | United States | $9.687B | 22.43 |
| Masimo (MASI) | United States | $8.725B | 32.29 |
| Teleflex (TFX) | United States | $5.328B | 8.79 |
| Glaukos (GKOS) | United States | $4.983B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.125B | 21.61 |
| TransMedics (TMDX) | United States | $3.159B | 92.46 |
| PROCEPT BioRobotics (PRCT) | United States | $2.945B | 0.00 |
| Veracyte (VCYT) | United States | $2.393B | 43.04 |
| LivaNova (LIVN) | United Kingdom | $1.917B | 11.60 |
| Elekta AB (EKTAY) | Sweden | $1.889B | 16.98 |
| Nihon Kohden (NHNKY) | Japan | $1.867B | 10.21 |
| Alphatec Holdings (ATEC) | United States | $1.779B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.420B | 0.00 |
| Artivion (AORT) | United States | $1.171B | 109.68 |
| Pulse Biosciences (PLSE) | United States | $1.113B | 0.00 |
| OPKO Health (OPK) | United States | $1.015B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.991B | 5.27 |
| AxoGen (AXGN) | United States | $0.747B | 0.00 |
| SiBone (SIBN) | United States | $0.700B | 0.00 |
| IRadimed (IRMD) | United States | $0.649B | 32.92 |
| Mesa Laboratories (MLAB) | United States | $0.641B | 14.01 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.591B | 9.24 |
| RxSight (RXST) | United States | $0.567B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.520B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.492B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.471B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.464B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.392B | 0.00 |
| NeuroPace (NPCE) | United States | $0.383B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.367B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.350B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.330B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.318B | 6.74 |
| Neuronetics (STIM) | United States | $0.296B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.230B | 13.94 |
| CVRx (CVRX) | United States | $0.194B | 0.00 |
| Inogen (INGN) | United States | $0.190B | 0.00 |
| 908 Devices (MASS) | United States | $0.190B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.182B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.164B | 0.00 |
| LENSAR (LNSR) | United States | $0.163B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.146B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.145B | 0.00 |
| Accuray (ARAY) | United States | $0.134B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.130B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.126B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.099B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.098B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.085B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.080B | 0.00 |
| InspireMD (NSPR) | Israel | $0.077B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.070B | 10.60 |
| EnVVeno Medical (NVNO) | United States | $0.061B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.054B | 0.00 |
| Hyperfine (HYPR) | United States | $0.052B | 0.00 |
| Positron (POSC) | United States | $0.052B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.048B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.035B | 0.00 | |
| Biosig Technologies (BSGM) | United States | $0.035B | 0.00 |
| Precision Optics (POCI) | United States | $0.034B | 0.00 |
| Envoy Medical (COCH) | United States | $0.032B | 0.00 |
| Spectral AI (MDAI) | United States | $0.030B | 0.00 |
| DarioHealth (DRIO) | United States | $0.029B | 0.00 |
| NexGel (NXGL) | United States | $0.020B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.019B | 0.00 |
| PAVmed (PAVM) | United States | $0.013B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.013B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.012B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.007B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.007B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.006B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 15.66 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |